As PTP1B modulates multiple processes in both Alzheimer’s disease and diabetes mellitus [65], 2(5H)-furanone has potential for the treatment of these conditions, although its effects are yet to be confirmed. The gene discussed is PTPN1; the disease is early-onset autosomal dominant Alzheimer disease.